Review
Open access
Sep 2026
Central nervous system efficacy of third generation vs. first generation EGFR-TKIs in the first line treatment for EGFR-mutated non-small cell lung cancer with central nervous system metastases: a systematic review and meta-analysis of phase 3 randomized controlled trials
TGET appeared to be better than FGET for patients with EGFR-mutated NSCLC and CNS metastases, showing improved survival, CNS efficacy, and safety.
Jiong-Li Gan, Shao-Feng Zhu, Yan Fang et al.
· Journal of Thoracic Disease · 0 citations